ProShare Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $934K | Buy |
|
|||||
|
2024
Q4 | $419K | Sell |
|
|||||
|
2024
Q3 | $457K | Sell |
|
|||||
|
2024
Q2 | $1.37M | Sell |
|
|||||
|
2024
Q1 | $1.63M | Buy |
|
|||||
|
2023
Q4 | $1.55M | Buy |
|
|||||
|
2023
Q3 | $961K | Buy |
|
|||||
|
2023
Q2 | $1.16M | Buy |
|
|||||
|
2023
Q1 | $939K | Sell |
|
|||||
|
2022
Q4 | $1.04M | Buy |
|
|||||
|
2022
Q3 | $840K | Buy |
|
|||||
|
2022
Q2 | $1.01M | Sell |
|
|||||
|
2022
Q1 | $1.51M | Sell |
|
|||||
|
2021
Q4 | $1.41M | Buy |
|
|||||
|
2021
Q3 | $986K | Sell |
|
|||||
|
2021
Q2 | $1.34M | Buy |
|
|||||
|
2021
Q1 | $981K | Buy |
|
|||||
|
2020
Q4 | $861K | Buy |
|
|||||
|
2020
Q3 | $484K | Buy |
|
|||||
|
2020
Q2 | $464K | Buy |
|
|||||
|
2020
Q1 | $186K | Sell |
|
|||||
|
2019
Q4 | $617K | Sell |
|
|||||
|
2019
Q3 | $149K | Sell |
|
|||||
|
2019
Q2 | $270K | Sell |
|
|||||
|
2019
Q1 | $287K | Buy |
|
|||||
|
2018
Q4 | $265K | Sell |
|
|||||
|
2018
Q3 | $603K | Sell |
|
|||||
|
2018
Q2 | $510K | Sell |
|
|||||
|
2018
Q1 | $645K | Sell |
|
|||||
|
2017
Q4 | $517K | Buy |
|
|||||
|
2017
Q3 | $423K | Buy |
|
|||||
|
2017
Q2 | $314K | Sell |
|
|||||
|
2017
Q1 | $439K | Sell |
|
|||||
|
2016
Q4 | $515K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $209K | Buy |
|